Our previous studies using TNF-Tg mice, a mouse model of rheumatoid arthritis (RA), demonstrated that inhibition of lymphangiogenesis via VEGFR-3 blockade increases [26], while stimulation of lymphangiogenesis via VEGF-C administration decreases the severity of joint inflammation and tissue damage [41]. The gene discussed is VEGFC; the disease is rheumatoid arthritis.